We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A mathematical model to estimate the number of cases of variant Creutzfeldt-Jakob Disease (vCJD) that could be caused by transfusions of blood products.
Papers on the transmission of variant Creutzfeldt-Jakob Disease (vCJD) from person to person though donated blood components.
Prevention of CJD and vCJD by the Advisory Committee on Dangerous Pathogens' Transmissible Spongiform Encephalopathy (ACDP TSE) subgroup.
The characteristics, diagnosis, management, surveillance and epidemiology of CJD.
This paper, including the emerging findings of the appendix prevalence study, was considered at the meeting of the Advisory Committee on Dangerous Pathogens Transmissible Spongiform Encephalopathy Risk Assessment Sub-Group on 14 July 2011.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
The Commission on Human Medicines (CHM) has concluded that the risk of vCJD cases arising from the use of UK plasma for the manufacture of immunoglobulin medicinal products would be negligible.
Updates on enhanced surveillance of potentially iatrogenic CJD exposures -- occasional reports related to human prion disease surveys.
Supporting paper prepared by the Environmental Modelling Group (EMG), EMG Transmission Group, and the Scientific Pandemic Insights Group on Behaviours (SPI-B).
Resilient energy networks are critical for energy security, and a strengthening of our electricity network will ensure we can meet challenges from an increasing diversified energy mix.
The NHSBT and UKHSA surveillance programme is a series of national schemes that monitors infection in blood, tissue and organ donors, and transfusion recipients.
Leading scientists at the independent Commission on Human Medicines (CHM) have confirmed that albumin, a critically important medicine for the NHS, can now be safely derived from UK plasma donors.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.